Global BCI and EEG Market Strategic Research Report

Scope of the Report

The global BCI and EEG market size is predicted to grow from US$ 953 million in 2025 to US$ 1,805 million in 2032; it is expected to grow at a CAGR of 9.7% from 2026 to 2032.

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.

An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.

Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.

This report presents a comprehensive overview of the global BCI and EEG market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Hardware
• Software and Service

Segment by players, this report covers

• Medtronic
• Natus Medical
• Nihon Kohden
• NeuroPace Inc
• Mindmaze SA
• G.TEC
• BrainCo
• InteraXon
• Brain Products GmbH
• EGI
• Blackrock Microsystems LLC
• Emotiv Inc
• Micromed
• ANT Neuro B.V
• Compumedics Limited
• NeuroSky, Inc.
• Artinis Medical Systems BV
• Cadwell
• Advanced Brain Monitoring
• NCC Medical
• SYMTOP
• Neuroelectrics

Segment by Application

• Medical
• Consumer

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global BCI and EEG market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medical, Consumer evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact